OUR MISSION
As an at-home blood collection device company, YourBio Health eliminates barriers to blood collection by allowing a capillary blood sample to be collected from any physical location without the pain of a fingerstick or need for traditional phlebotomy. Backed by the latest science, data management technology, and certified central laboratories, we guarantee best-in-class test results.
OUR MISSION
YourBio Health eliminates barriers to blood collection by allowing a patient blood sample to be collected from any physical location without the pain of a fingerstick or need for traditional phlebotomy. Backed by the latest science, data management technology, and certified central laboratories, we guarantee best-in-class test results.
our history
TAP®, “Touch Activated Phlebotomy”, was invented in Flagship’s lab to decentralize blood-based testing, a sample can be collected anywhere and delivered to a lab more conveniently, with less pain. We invented a technology for self collecting capillary blood which easy to use and virtually painless.
Today, our device and service envelop is used in clinical trials and wellness applications globally.

our product
Traditional methods of blood draw through venipuncture usually require a visit to a clinic, lab or healthcare professional; where fingersticks typically involve discomfort and anxiety for the patient.
Unlike many blood collection companies, YourBio Health allows patients to easily draw with less pain and from the comfort of home or any other location they choose with our TAP II device.
TAP II is placed on the upper arm and blood collection starts with a simple press of a button. The process typically takes 2-3 minutes. This innovation provides easier and more cost-effective access to high quality central lab testing and is a game-changer for consumers, the health care system, and patients.
- TAP II is currently CE Marked and available in select European countries.
- TAP II is available for investigational use only (IUO) in the US and is not yet FDA cleared.
our team
Harry
Wilcox
Executive Chairman
Jerry Brightbill
Chief Operating Officer
Hutan Ashrafian
Chief Medical Officer
Sara Gilbert Leonard
Chief Marketing Officer
Stephen Hahn
Medical Advisor
Ros Barker
Commercial Director, UK and EU
Vinny Barone
Director of Engineering
Douglas Woodbury
Director of Quality
our board of directors
Noubar Afeyan
CEO,
Flagship Pioneering
Thomas J. Cahill, MD, PhD
Founder and Managing Partner,
Newpath Partners LLC
Don Hardison
President, CEO and
Director of Biotheranostics, Inc.
Peter Hutt, JD
Senior Counsel,
Covington & Burling, LLP
Robert Langer, ScD
(Co-founder)
Institute Professor, MIT
Harry Wilcox
General Partner,
Flagship Pioneering
Ara Darzi
Chairman, Preemptive Medicine and Health Security Initiative,
Flagship Pioneering